Apr 09, 2018
Forge Announces Oral Presentation On Development Of Novel Antibiotics At The 28th Annual ECCMID Meeting
Mar 27, 2018
Arrevus announces receipt of NIH grant to support research using ARV-1502 to combat antibiotic-resistant wound infections
Mar 21, 2018
Forge Therapeutics To Present At The 2018 Needham & Company Healthcare Conference
Mar 08, 2018
Prokaryotics Receives $2.5 Million SBIR Grant to Support Novel Antibiotic Program
Feb 22, 2018
Global Antibacterial Therapeutics Research Report 2018: The Antibacterial Pipeline is Large, with 1,634 Products in Active Development
Feb 15, 2018
Debiopharm Continues the Fight Against Antibiotic Resistance With Investment in ABAC Therapeutics Inc.
Feb 15, 2018
ABAC Therapeutics Announces EUR16 Million Series A to Develop Therapeutic Solutions to Fight Antibiotic-Resistant Bacteria
Feb 13, 2018
Antibiotics developer Octagon Therapeutics closes financing, adds thought leaders
Jan 25, 2018
Prokaryotics Announces Licensing Agreement with Merck for Novel Investigational Antibiotic Candidates
Jan 23, 2018
Superbugs: First Independent Comparison of Pharma Companies' Efforts to Address Drug-resistant Infections
Jan 23, 2018
Silver Offers Hope of Solving the Antibiotics Crisis - Bacterial Resistance to Nanoparticles can be Averted
Jan 10, 2018
Fighting antibiotic resistance: CDC tool maps progress in every state, but still more to be done
Jan 04, 2018
VenatoRx Pharmaceuticals Receives Award for up to $16 Million from DTRA to Develop a Novel, First-in-Class Antibiotic as Countermeasure against Potential Drug-Resistant Biodefense Category A/B Respiratory Pathogens
Dec 14, 2017
Antibacterial Drugs Market Value to Reach US$51,447.6 Million by the End of 2025: Transparency Market Research
Dec 12, 2017
Novasep Signs Manufacturing Agreement with Clinical-stage Biopharmaceutical Company Tetraphase for Eravacycline API
Nov 16, 2017
CDC Encourages Safe Antibiotic Prescribing and Use
Oct 31, 2017
Forge Therapeutics And Collaborators From Evotec And USC Present New Efficacy Data At 2017 Keystone Symposia Conference
Oct 31, 2017
Inhibrx Wins CARB-X Award Of Up To $6.0M To Accelerate Development Of Its Novel Antibody, INBRX-111, To Treat Pseudomonas Infections
Oct 11, 2017
Forge Therapeutics To Participate In Antimicrobial Resistance Panel At 2017 BIO Investor Forum
Oct 05, 2017
AMR Centre Deal With Medivir Targets Superbug Time-bomb